By Marcia Dunn
NASA held its first public meeting on UFOs Wednesday a year after launching a study into unexplained sightings.
The space agency televised the hourslong hearing featuring an independent panel of experts. The team includes 16 scientists and other experts selected by NASA including retired astronaut Scott Kelly, the first American to spend nearly a year in space.
Several committee members have been subjected to “online abuse” for serving on the team, which detracts from the scientific process, said NASA's Dan Evans, adding that NASA security is dealing with it.
“It’s precisely this rigorous, evidence-based approach that allows one to separate the fact from fiction," Evans said.
The study is a first step in trying to explain mysterious sightings in the sky that NASA calls UAPs, or unidentified aerial phenomena.
The group is looking at what unclassified information is available on the subject and how much more is needed to understand what's going on in the sky, according to astrophysicist David Spergel, the committee's chair who runs the Simons Foundation.
No secret military data are included, such as anything surrounding the suspected spy balloons from China spotted flying over the U.S. earlier this year.
The meeting was held at at NASA headquarters in Washington with the public taking part remotely.
A final report is expected by the end of July.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Despite the expected arrival of COVID-19 vaccines in just a few weeks, it could take several months — probably well into 2021 — before things get back to something close to normal in the United States.
American Airlines is expanding its COVID-19 pilot pre-flight testing program to London in an effort to get more international flyers in the sky.
AstraZeneca reported that its vaccine is 90% effective and cheaper to distribute than vaccines from its competitors. Meanwhile, the U.S. is averaging 1,500 deaths per day according to Johns Hopkins.
Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals.
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.
A satellite jointly developed by Europe and the United States being launched this weekend will greatly help scientists keep track of the rise in global sea levels, one of the most daunting effects of climate change, a senior official at the European Space Agency said Friday.
The use of mRNA technology in COVID-19 vaccines is groundbreaking for a number of reasons. However, there is a drawback to the vaccines: they have to be stored in brutally cold temperatures.
The U.S. decline in cigarette smoking could be stalling while the adult vaping rate appears to be rising, according to a government report released Thursday.
The only known white giraffe in the world has been fitted with a GPS tracking device to help protect it from poachers as it grazes in Kenya.
Pfizer said Wednesday that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying.
